These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16700798)

  • 21. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An uncommon presentation of the co-existence of morphea and vitiligo in a patient with chronic hepatitis B virus infection: is there a possible association with autoimmunity?
    Soylu S; Gül U; Gönül M; Kiliç A; Cakmak SK; Demiriz M
    Am J Clin Dermatol; 2009; 10(5):336-8. PubMed ID: 19658447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
    Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
    J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies.
    Sant'Anna-Silva ACB; Botton T; Rossi A; Dobner J; Bzioueche H; Thach N; Blot L; Pagnotta S; Kleszczynski K; Steinbrink K; Mazure NM; Rocchi S; Krutmann J; Passeron T; Tulic MK
    Clin Transl Med; 2024 Aug; 14(8):e1810. PubMed ID: 39113238
    [No Abstract]   [Full Text] [Related]  

  • 25. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population.
    Kim HJ; Choi CP; Uhm YK; Kim YI; Lee JW; Yoon SH; Chung JH; Lee MH
    Exp Dermatol; 2007 Jul; 16(7):561-6. PubMed ID: 17576235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter to the editor.
    Wollina U; Schreiber G
    Int J Dermatol; 2005 Jul; 44(7):617. PubMed ID: 15985041
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: "Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study".
    Amerson EH; Murphy E
    J Am Acad Dermatol; 2016 Dec; 75(6):e231. PubMed ID: 27846972
    [No Abstract]   [Full Text] [Related]  

  • 28. Vitiligo is not a cosmetic disease.
    Ezzedine K; Sheth V; Rodrigues M; Eleftheriadou V; Harris JE; Hamzavi IH; Pandya AG;
    J Am Acad Dermatol; 2015 Nov; 73(5):883-5. PubMed ID: 26475548
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to: "Re: Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study".
    Hamzavi IH; Zarbo A; Lim HW
    J Am Acad Dermatol; 2016 Dec; 75(6):e233. PubMed ID: 27846973
    [No Abstract]   [Full Text] [Related]  

  • 30. Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?
    Ram M; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Sep; 1110():410-25. PubMed ID: 17911456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study.
    Basak PY; Adiloglu AK; Koc IG; Tas T; Akkaya VB
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):970-6. PubMed ID: 18482314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between family medical history and childhood vitiligo.
    Pajvani U; Ahmad N; Wiley A; Levy RM; Kundu R; Mancini AJ; Chamlin S; Wagner A; Paller AS
    J Am Acad Dermatol; 2006 Aug; 55(2):238-44. PubMed ID: 16844505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis of melanocytes in vitiligo results from antibody penetration.
    Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
    J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population.
    Laddha NC; Dwivedi M; Shajil EM; Prajapati H; Marfatia YS; Begum R
    J Dermatol Sci; 2008 Mar; 49(3):260-2. PubMed ID: 18037273
    [No Abstract]   [Full Text] [Related]  

  • 35. [Expression and purification of epitope peptide of human tyrosinase and its antigenicity in vitiligo patients].
    Guan CP; Zhou MN; Li YW; Wei XD; Xu AE
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2408-11. PubMed ID: 18036319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of HLA loci alleles and antigens in Saudi patients with vitiligo.
    Abanmi A; Al Harthi F; Al Baqami R; Al Assaf S; Zouman A; Arfin M; Tariq M
    Arch Dermatol Res; 2006 Dec; 298(7):347-52. PubMed ID: 17021767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.
    Amerio P; Tracanna M; De Remigis P; Betterle C; Vianale L; Marra ME; Di Rollo D; Capizzi R; Feliciani C; Tulli A
    Clin Exp Dermatol; 2006 Sep; 31(5):746-9. PubMed ID: 16803462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies.
    Gavalas NG; Gottumukkala RV; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
    Exp Dermatol; 2009 May; 18(5):454-63. PubMed ID: 19320743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ACE gene I/ D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population.
    Dwivedi M; Laddha NC; Shajil EM; Shah BJ; Begum R
    Pigment Cell Melanoma Res; 2008 Jun; 21(3):407-8. PubMed ID: 18444962
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of the innate immune response in autoimmune disease.
    Lang KS; Burow A; Kurrer M; Lang PA; Recher M
    J Autoimmun; 2007 Dec; 29(4):206-12. PubMed ID: 17904335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.